MCID: CRN027
MIFTS: 42

Corneal Neovascularization malady

Eye diseases category

Aliases & Classifications for Corneal Neovascularization

About this section
Sources:
10Disease Ontology, 47Novoseek, 65UMLS, 36MeSH, 29ICD9CM, 59SNOMED-CT, 27ICD10
See all sources

Aliases & Descriptions for Corneal Neovascularization:

Name: Corneal Neovascularization 10 47 65 36
Corneal Neovascularization, Unspecified 10
 
Unspecified Corneal Neovascularization 10
Corneal Neovascularization Nos 10


Classifications:



External Ids:

Disease Ontology10 DOID:11382
ICD9CM29 370.6, 370.60
MeSH36 D016510
ICD1027 H16.4

Summaries for Corneal Neovascularization

About this section
Wikipedia:68 Corneal neovascularization is the excessive ingrowth of blood vessels from the limbal vascular plexus... more...

MalaCards based summary: Corneal Neovascularization, also known as corneal neovascularization, unspecified, is related to retinitis and corneal ulcer. An important gene associated with Corneal Neovascularization is VEGFA (Vascular Endothelial Growth Factor A), and among its related pathways are Integrins in angiogenesis and S1P3 pathway. Affiliated tissues include eye, endothelial and neutrophil, and related mouse phenotypes are tumorigenesis and skeleton.

Related Diseases for Corneal Neovascularization

About this section

Diseases related to Corneal Neovascularization via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1retinitis30.3PLG, VEGFA
2corneal ulcer27.6CD36, CXCL12, FGF2, FLT1, HRG, KDR
3burns10.7
4endotheliitis10.7
5keratitis10.6
6spiradenoma10.6
7corneal disease10.6
8eye disease10.6
9globe disease10.6
10auditory system disease10.4
11stromal keratitis10.4
12keratopathy10.3
13malignant cardiac germ cell tumor10.3FLT1, VEGFA
14obesity due to melanocortin 4 receptor deficiency10.3FLT1, VEGFA
15subacute leukemia10.2FLT1, VEGFA
16gastric antral vascular ectasia10.2FGF2, VEGFA
17anatomical narrow angle borderline glaucoma10.2SERPINF1, VEGFA
18limbal stem cell deficiency10.2
19phototoxic dermatitis10.2
20corneal deposit10.2
21corneal edema10.2
22hypoxia10.2
23lipodystrophy due to peptidic growth factors deficiency10.2FLT1, VEGFA
24cowper gland carcinoma10.2SERPINF1, VEGFA
25vestibule of mouth cancer10.2FGF2, SERPINF1, VEGFA
26male reproductive organ benign neoplasm10.2CXCL12, SERPINF1, VEGFA
27osteogenesis imperfecta, type iii10.2CD36, SERPINF1
28lower lip cancer10.2FLT1, VEGFA
29early-onset, autosomal dominant alzheimer disease10.1SERPINF1, VEGFA
30calcinosis10.1CXCL12, KDR
31skin melanoma10.1KDR, VEGFA
32caplan's syndrome10.1KDR, SERPINF1, VEGFA
33indolent systemic mastocytosis10.1FLT1, KDR, VEGFA
34lymphatic system cancer10.1KDR, SERPINF1, VEGFA
35warty dyskeratoma10.1FGF2, KDR, VEGFA
36heart lymphoma10.1FGF2, KDR, VEGFA
37hypospadias - hypertelorism - coloboma and deafness10.1FLT1, KDR, VEGFA
38anemia, sideroblastic, pyridoxine-refractory, autosomal recessive10.1
39brain small vessel disease with or without ocular anomalies10.1
40pick disease10.1
41corneal intraepithelial dyskeratosis and ectodermal dysplasia10.1
42peripheral vascular disease10.1
43tongue squamous cell carcinoma10.1
44iritis10.1
45cornea squamous cell carcinoma10.1
46infectious anterior uveitis10.1
47cicatricial pemphigoid10.1
48exposure keratitis10.1
49eye carcinoma10.1
50mooren's ulcer10.1

Graphical network of the top 20 diseases related to Corneal Neovascularization:



Diseases related to corneal neovascularization

Symptoms for Corneal Neovascularization

About this section

Drugs & Therapeutics for Corneal Neovascularization

About this section

Drugs for Corneal Neovascularization (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 38)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bevacizumabapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 11820216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
2
FluoresceinapprovedPhase 41042321-07-516850
Synonyms:
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid
3',6'-dihydroxyfluoran
3,6-fluorandiol
9-(o-carboxyphenyl)-6-hydroxy-3-isoxanthenone
9-(o-carboxyphenyl)-6-hydroxy-3H-xanthen-3-one
Ak-fluor
C.I. Solvent Yellow 94
D and C Yellow No. 7
 
D&C Yellow No. 7
Fluorescein disodium
Fluoresceine
Fluorescite
Fluoreszein
Japan Yellow 201
Resorcinolphthalein
Solvent Yellow 94
Yellow fluorescein
3
TriamcinoloneapprovedPhase 2, Phase 3429124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Allernaze
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
MLS000028542
MLS001066543
 
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone Acetonide
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Trianex
Triatex
Tricortale
Triderm
Triesence
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
4
OxytetracyclineapprovedPhase 2, Phase 3879-57-25280972
Synonyms:
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2E,4S,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
102287-29-6
103351-03-7
105145-10-6
106216-57-3
1405-95-4
15251-48-6
2058-46-0 (Mono-hydrochloride)
2058-46-0 (mono-hydrochloride)
21645-09-0
4-14-00-02633 (Beilstein Handbook Reference)
5-Hydroxy-Tetracycline
5-Hydroxytetracycline
52214-46-7
6153-64-6 (Di-hydrate)
6153-64-6 (di-hydrate)
6153-65-7 (Di-hydrochloride salt, di-hydrate)
6153-65-7 (di-hydrochloride salt, di-hydrate)
64038-91-1 (sulfate (2:1))
69766-62-7 (hydrochloride salt)
7179-50-2 (Calcium (1:1) salt)
7179-50-2 (calcium (1:1) salt)
79-57-2
79-57-2 (ANHYDROUS)
856305-69-6
96310-42-8
AC-12777
AC1NQXTY
AC1NQZMP
AC1NS4NE
AC1O52HP
AKOS001632631
Abbocin
Adamycin
Antibiotic TM 25
BPBio1_000302
BRN 2714587
BSPBio_000274
BSPBio_002151
Berkmycen
Biostat
Biostat PA
Biostat pa
Bisolvomycin
C06624
C22H24N2O9
CHEBI:27701
CHEMBL1517
CID5280972
CID5282186
CID5353856
CID6426716
DB00595
Dabicycline
Dalimycin
DivK1c_000225
EINECS 201-212-8
Embryostat
Fanterrin
Galsenomycin
Geomycin
Geomycin (Streptomyces vimosus)
Geotilin
HSDB 3145
Hydroxytetracycline
Hydroxytetracyclinum
IDI1_000225
Imperacin
KBio1_000225
KBio2_001535
KBio2_004103
KBio2_006671
KBio3_001651
KBioGR_000912
KBioSS_001535
LA 200
LMPK07000005
LS-93860
Lenocycline
Liquamycin
Liquamycin LA 200
 
MLS000069429
Macocyn
Medamycin
Mepatar
MolPort-002-524-946
MolPort-005-934-326
Mycoshield TMQTHC 20
NCGC00091268-04
NCGC00091268-05
NCI-C56473
NINDS_000225
NSC 9169
NSC-9169
NSC9169 (HCL)
OTC
OTC (antibiotic)
Oksisyklin
Ossitetraciclina
Ossitetraciclina [DCIT]
Oxacycline
Oxitetraciclina
Oxitetraciclina [INN-Spanish]
Oxitetracyclin
Oxitetracycline
Oxitetracyclinum
Oxy-kesso-tetra
Oxydon
Oxymycin
Oxymykoin
Oxypam
Oxysteclin
Oxyterracin
Oxyterracine
Oxyterracyne
Oxytetracid
Oxytetracyclin
Oxytetracycline (anhydrous)
Oxytetracycline (internal use)
Oxytetracycline HCl
Oxytetracycline Hydrochloride
Oxytetracycline [INN]
Oxytetracycline [inn]
Oxytetracycline amphoteric
Oxytetracycline anhydrous
Oxytetracycline calcium
Oxytetracyclinum
Oxytetracyclinum [INN-Latin]
Oxytétracycline
Pennox 200
Prestwick0_000307
Prestwick1_000307
Prestwick2_000307
Prestwick3_000307
Proteroxyna
Riomitsin
Ryomycin
S1773_Selleck
SMR000059000
SPBio_001055
SPBio_002493
STOCK1N-50853
Solkaciclina
Spectrum2_000988
Spectrum3_000536
Spectrum4_000466
Spectrum5_001148
Spectrum_001055
Stecsolin
Stevacin
TM 5
Tarocyn
Tarosin
Teravit
Terrafungine
Terramitsin
Terramycin
Terramycin Q50
Terramycin im
Terramycin, Liquamycin, Oxytetracycline
Tetran
UNII-SLF0D9077S
UNII-X20I9EN955
Unimycin
Ursocyclin
Ursocycline
Vendarcin
oxytetracycline
5
Doxycyclineapproved, investigationalPhase 2, Phase 3204564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
6Triamcinolone diacetatePhase 2, Phase 3429
7triamcinolone acetonidePhase 2, Phase 3429
8Triamcinolone hexacetonidePhase 2, Phase 3429
9LaxativesPhase 1, Phase 2278
10CatharticsPhase 1, Phase 2278
11Carboxymethylcellulose SodiumPhase 1, Phase 297
12Interleukin 1 Receptor Antagonist ProteinPhase 1, Phase 235
13TetrahydrozolinePhase 1, Phase 2484
14
TropicamideapprovedPhase 1211508-75-45593
Synonyms:
(+-)-N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
1508-75-4
5-22-09-00359 (Beilstein Handbook Reference)
AB00052120
AC-816
AC1L1KOZ
AC1Q5IFA
AR-1K6980
Akorn Brand of Tropicamide
Alcon Brand of Tropicamide
BPBio1_000303
BRD-A79672927-001-05-8
BRN 0285563
BSPBio_000275
BSPBio_002289
Bio-0810
Bistropamide
Bournonville Brand of Tropicamide
CHEMBL1200604
CID5593
CPD000058523
Cahill May Roberts Brand of Tropicamide
Chauvin Brand of Tropicamide
Colircusi Tropicamida
D00397
D014331
DB00809
DivK1c_000448
EINECS 216-140-2
EU-0101223
Epitromina
HMS1568N17
HMS1921I09
HMS2089M05
HMS2092A18
HMS501G10
I-Picamide
I06-0811
IDI1_000448
KBio1_000448
KBio2_001064
KBio2_003632
KBio2_006200
KBio3_001509
KBioGR_000873
KBioSS_001064
L001262
LS-28545
Lopac0_001223
MLS001306442
MLS002154240
Medical Ophthalmics Brand of Tropicamide
Minims tropicamide
MolPort-000-159-321
Mydral
Mydriacyl
Mydriacyl (TN)
Mydriafair
Mydriaticum
Mydrum
N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
N-Ethyl-2-phenyl-N-4-[-pyridyl-methyl]hydracrylamide
N-Ethyl-N-(4-pyridylmethyl)tropamid
N-Ethyl-N-(4-pyridylmethyl)tropamide
N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide
NCGC00016065-03
NCGC00016065-08
 
NCGC00024866-02
NCGC00024866-03
NCGC00024866-04
NCGC00024866-05
NCGC00024866-06
NINDS_000448
Novartis Brand of Tropicamide
Ocu Tropic
Ocu-Tropic
OcuTropic
Ocumed Brand of Tropicamide
Ocusoft Brand of Tropicamide
Opticyl
Paremyd
Pharmafair Brand of Tropicamide
Prestwick0_000228
Prestwick1_000228
Prestwick2_000228
Prestwick3_000228
Prestwick_487
Rivex Brand of Tropicamide
Ro 1-7683
SAM002564235
SMP1_000304
SMR000058523
SPBio_000872
SPBio_002196
SPECTRUM1500599
STK934612
Spectro-Cyl
Spectrum2_000936
Spectrum3_000655
Spectrum4_000377
Spectrum5_001585
Spectrum_000584
Stulln Brand 1 of Tropicamide
Stulln Brand 2 of Tropicamide
T 9778
T9778_SIGMA
TL8001101
Triaminic DM
Tropicacyl
Tropicamid
Tropicamida
Tropicamida [INN-Spanish]
Tropicamide
Tropicamide (JP15/USP/INN)
Tropicamide Alcon Brand
Tropicamide Chauvin Brand
Tropicamide Faure
Tropicamide Minims
Tropicamide Monofree
Tropicamide Monohydrochloride, (R)-Isomer
Tropicamide Monohydrochloride, (S)-Isomer
Tropicamide Novartis Brand
Tropicamide Ocumed Brand
Tropicamide Pharmafair Brand
Tropicamide Rivex Brand
Tropicamide [USAN:INN:BANJAN]
Tropicamide, (+-)-Isomer
Tropicamide, (R)-Isomer
Tropicamide, (S)-Isomer
Tropicamidum
Tropicamidum [INN-Latin]
Tropikamid
Tropimil
UNII-N0A3Z5XTC6
Visumidriatic
n-ethyl-n-(g-picolyl)tropamide
tropicamide
15
EphedrineapprovedPhase 1438299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
16
PseudoephedrineapprovedPhase 143890-82-47028
Synonyms:
( )-Pseudoephedrine
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D-Psi-ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephed 60
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-Psi-ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine Hydrochloride
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrine hydrochloride
Pseudoephedrine sulfate
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Suphedrine
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
trans-Ephedrine
17
BetamethasoneapprovedPhase 1145378-44-99782
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16β-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
BIDD:PXR0047
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone Base
Betamethasone Dipropionate
Betamethasone Valearate
Betamethasone Valerate
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone cream
Betamethasone dipropionate
Betamethasone sodium phosphate
Betamethasone valerate
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
 
Betasolon
Betnelan
Betsolan
C22H29FO5
CHEBI:3077
CHEMBL632
CID3003
CID9782
CPD000339803
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
Cidoten
D00244
D1961
DB00443
Desacort-Beta
Diprolene
EINECS 206-825-4
Flubenisolone
HMS1569I05
HSDB 3015
Hormezon
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
MLS-0310139.0001
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
Methazon
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC-39470
NSC39470
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Prestwick_703
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
beta-Methasone
beta-Methasone alcohol
betamethasone
18
ZincapprovedPhase 114047440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
19Insulin, Globin ZincPhase 14069
20MydriaticsPhase 1470
21Nasal DecongestantsPhase 1406
22GentamicinsPhase 1119
23Betamethasone benzoatePhase 1145
24insulinPhase 14069
25Betamethasone sodium phosphatePhase 1145
26Betamethasone ValeratePhase 11452152-44-5
27Betamethasone-17,21-dipropionatePhase 1145
28Immunoglobulins, IntravenousPhase 1203
29Rho(D) Immune GlobulinPhase 1198
30CyclosporinsPhase 1849
31
Verteporfinapproved, investigational82129497-78-55362420
Synonyms:
Verteporfin
Verteporfina
 
Verteporfinum
Vertéporfine
Visudyne
32
Prednisoloneapproved103350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
33
Methylprednisoloneapproved103383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
34Prednisolone phosphate1033
35Prednisolone hemisuccinate1033
36Prednisolone acetate1033
37Methylprednisolone acetate1033
38Methylprednisolone Hemisuccinate1033

Interventional clinical trials:

(show all 48)
idNameStatusNCT IDPhase
1The Effect of Bevacizumab on Corneal NeovascularizationCompletedNCT00797303Phase 4
2Clinical Performance of Biofinity Toric Versus Air Optix for AstigmatismCompletedNCT01965288Phase 4
3Strategies for Management of Corneal NeovascularisationNot yet recruitingNCT02594423Phase 4
4Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell DeficiencyNot yet recruitingNCT02577861Phase 4
5Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCompletedNCT00555594Phase 2, Phase 3
6The Role of Amniotic Membrane Transplantation in Ocular Chemical BurnsRecruitingNCT00370812Phase 2, Phase 3
7Efficacy and Safety Study of Avastin to Treat Neovascularisation of the CorneaRecruitingNCT01501760Phase 3
8Low Dose Doxycycline in the Treatment of Corneal BurnNot yet recruitingNCT01886560Phase 2, Phase 3
9Treatment of Corneal Neovascularization With Topical PazopanibCompletedNCT01257750Phase 1, Phase 2
10Topical IL-1-Ra for Treatment of Corneal NeovascularizationCompletedNCT00915590Phase 1, Phase 2
11Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalCompletedNCT01072357Phase 1, Phase 2
12Amniotic Membrane Graft In Syntomathic Bullous KeratopathyCompletedNCT01926535Phase 2
13Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex VivoCompletedNCT01470573Phase 2
14Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) PatientsCompletedNCT00736307Phase 1, Phase 2
15Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot StudyRecruitingNCT01843101Phase 2
16A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalRecruitingNCT01996826Phase 1, Phase 2
17Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective DoseRecruitingNCT02157987Phase 1, Phase 2
18Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell DeficiencyRecruitingNCT01756365Phase 1, Phase 2
19Bevacizumab for the Treatment of Corneal NeovascularizationActive, not recruitingNCT00992849Phase 2
20Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell DeficiencyActive, not recruitingNCT00845117Phase 1, Phase 2
21Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter TrialNot yet recruitingNCT02318485Phase 2
22Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar KeratoplastyNot yet recruitingNCT02424006Phase 1, Phase 2
23Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell DeficiencySuspendedNCT00348114Phase 2
24Topical Avastin for Treatment of Corneal NeovascularizationCompletedNCT00559936Phase 1
25Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)CompletedNCT00681889Phase 1
26Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant SurgeryCompletedNCT00769145Phase 1
27Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01075347Phase 1
28Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01031888Phase 1
29The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)CompletedNCT02649621Phase 1
30Ranibizumab for the Inhibition of Neovascularization in PterygiaCompletedNCT00768963Phase 1
31Bevacizumab Injection for Recurrent PterygiumCompletedNCT02007174Phase 1
32Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory ConditionsRecruitingNCT02042027Phase 1
33Evaluation of Biosynthetic Constructs to Replace Donor CorneasNot yet recruitingNCT02374723Phase 1
34Using Aflibercept Injection to Treat Blood Vessel Growth Over the CorneaTerminatedNCT01868360Phase 1
35Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal NeovascularizationCompletedNCT00512876
36Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal NeovascularizationCompletedNCT00004430
37Photodynamic Therapy With Verteporfin for Corneal NeovascularizationCompletedNCT00471406
38Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal NeovasculizationCompletedNCT00681603
39Vistakon Investigational Lens Worn as a Single Use Daily WearCompletedNCT01031004
40Assessment of Daily Disposable Silicone Hydrogel Lens WearCompletedNCT01093625
41Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to TrabeculectomyCompletedNCT01425112
42Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact LensesCompletedNCT00382902
43Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic PatientsCompletedNCT00382603
44Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular DiseasesRecruitingNCT02448732Phase 0
45Neovascularization Patterns in Corneal Graft RejectionActive, not recruitingNCT01695655
46Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical StudyNot yet recruitingNCT02637804
47Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture MediaNot yet recruitingNCT00623584
48Corneal Thinning During Topical Bevacizumab TherapyWithdrawnNCT00515684

Search NIH Clinical Center for Corneal Neovascularization


Cochrane evidence based reviews: Corneal Neovascularization

Genetic Tests for Corneal Neovascularization

About this section

Anatomical Context for Corneal Neovascularization

About this section

MalaCards organs/tissues related to Corneal Neovascularization:

33
Eye, Endothelial, Neutrophil, Brain

Animal Models for Corneal Neovascularization or affiliated genes

About this section

MGI Mouse Phenotypes related to Corneal Neovascularization:

38 (show all 17)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.8FGF2, PLG, ROBO1, THBS1, VEGFA
2MP:00053908.7CD36, FGF2, KDR, ROBO1, THBS1, VEGFA
3MP:00053708.5CD36, CXCL12, KDR, PLG, THBS1, VEGFA
4MP:00053678.2CD36, PLG, ROBO1, SLIT2, THBS1, VEGFA
5MP:00107718.2KDR, PLG, ROBO1, SLIT2, THBS1, VEGFA
6MP:00053918.1CD36, FGF2, FLT1, KDR, PLG, SERPINF1
7MP:00053818.0CD36, PLG, ROBO1, SERPINF1, SLIT2, THBS1
8MP:00053797.6CD36, PLG, ROBO1, SERPINF1, SLIT2, THBS1
9MP:00053697.4CD36, CXCL12, FGF2, FLT1, KDR, ROBO1
10MP:00053897.2CXCL12, FGF2, FLT1, PLG, ROBO1, SERPINF1
11MP:00053877.0CD36, CXCL12, FLT1, HRG, KDR, PLG
12MP:00053856.7CD36, CXCL12, FGF2, FLT1, KDR, PLG
13MP:00053766.5CD36, FGF2, FLT1, HRG, KDR, PLG
14MP:00053846.4CD36, CXCL12, FGF2, FLT1, KDR, PLG
15MP:00036316.4CD36, CXCL12, FGF2, FLT1, KDR, PLG
16MP:00107686.3CD36, CXCL12, FGF2, FLT1, KDR, PLG
17MP:00053976.3CD36, CXCL12, FGF2, FLT1, HRG, KDR

Publications for Corneal Neovascularization

About this section

Articles related to Corneal Neovascularization:

(show top 50)    (show all 376)
idTitleAuthorsYear
1
Corneal Angiography for Guiding and Evaluating Fine-Needle Diathermy Treatment of Corneal Neovascularization. (25841974)
2015
2
Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats. (25853509)
2015
3
Intrastromal bevacizumab injection for corneal neovascularization in herpetic stromal keratitis. (26342658)
2015
4
Keratocytes Create Stromal Spaces to Promote Corneal Neovascularization Via MMP13 Expression. (25190659)
2014
5
Biometric risk factors for corneal neovascularization associated with hydrogel soft contact lens wear in Korean myopic patients. (25120337)
2014
6
Antiangiogenic Effect of Itraconazole on Corneal Neovascularization: A Pilot Experimental Investigation. (25342430)
2014
7
Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization. (25090164)
2014
8
Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy. (25540752)
2014
9
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model. (24145627)
2013
10
The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits. (23739149)
2013
11
Corneal neovascularization: An enigma. (24379562)
2013
12
High-dose topical bevacizumab for corneal neovascularization. (24335191)
2013
13
The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization. (23404727)
2013
14
Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis. (22668582)
2013
15
The association between corneal neovascularization and visual acuity: a systematic review. (22103683)
2013
16
Inhibition of Corneal Neovascularization with the Combination of Bevacizumab and Plasmid Pigment Epithelium-Derived Factor-Synthetic Amphiphile INTeraction-18 (p-PEDF-SAINT-18) Vector in a Rat Corneal Experimental Angiogenesis Model. (23591843)
2013
17
Minocycline inhibits alkali burn-induced corneal neovascularization in mice. (22848638)
2012
18
Corneal neovascularization: an anti-VEGF therapy review. (22898649)
2012
19
Preliminary studies of the effects of vascular adhesion protein-1 inhibitors on experimental corneal neovascularization. (21331460)
2011
20
(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization. (20971568)
2011
21
Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats. (21212709)
2011
22
The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats. (20953876)
2011
23
Potential anti-angiogenic role of Slit2 in corneal neovascularization. (20298689)
2010
24
Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. (21077280)
2010
25
The effect of bevacizumab on corneal neovascularization in rabbits. (20714387)
2010
26
Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model. (20591397)
2010
27
Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization. (18953554)
2009
28
Bevacizumab for corneal neovascularization. (19264217)
2009
29
Corneal neovascularization and ocular irritancy responses in dogs following topical ocular administration of an EP4-prostaglandin E2 agonist. (20008547)
2009
30
Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. (18812781)
2008
31
Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. (18214740)
2008
32
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. (17198016)
2007
33
The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization. (16783147)
2006
34
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. (15851564)
2005
35
Gene expression profile in corneal neovascularization identified by immunology related macroarray. (15547492)
2004
36
Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo. (14687476)
2003
37
Angiostatin inhibits and regresses corneal neovascularization. (12149060)
2002
38
Lipid hydroperoxide induced corneal neovascularization in hyperglycemic rabbits. (12518243)
2002
39
Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. (11521696)
2001
40
Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na). (10976562)
2000
41
Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. (10474071)
1999
42
Photodynamic therapy for corneal neovascularization. (9793949)
1998
43
Treatment of corneal neovascularization with argon laser. (8230778)
1993
44
Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. (2473047)
1989
45
Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. (2459642)
1988
46
Corneal neovascularization in contact lens wearers. (2419272)
1986
47
Corneal effect of isotretinoin: possible exacerbation of corneal neovascularization in a patient with the keratitis, ichthyosis, deafness ("KID") syndrome. (2419373)
1986
48
Experimental corneal neovascularization: biomicroscopic, angiographic, and morphologic correlation. (2419029)
1985-1986
49
The effects of leukocyte depletion on corneal neovascularization. (621924)
1978
50
Argon laser treatment of corneal neovascularization. (4582809)
1973

Variations for Corneal Neovascularization

About this section

Expression for genes affiliated with Corneal Neovascularization

About this section
Search GEO for disease gene expression data for Corneal Neovascularization.

Pathways for genes affiliated with Corneal Neovascularization

About this section

Pathways related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 33)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6FGF2, KDR, VEGFA
2
Show member pathways
9.6FLT1, KDR, VEGFA
3
Show member pathways
9.6FLT1, KDR, VEGFA
49.6FLT1, KDR, VEGFA
5
Show member pathways
9.6FLT1, KDR, VEGFA
69.6FLT1, KDR, VEGFA
79.6FLT1, KDR, VEGFA
89.5FLT1, TEK, VEGFA
99.5FLT1, KDR, TEK
109.3HRG, PLG
11
Show member pathways
9.3FGF2, FLT1, KDR, VEGFA
129.3FGF2, FLT1, KDR, VEGFA
13
Show member pathways
9.3FGF2, FLT1, KDR, VEGFA
149.3FGF2, KDR, PLG, VEGFA
15
Angiogenesis (CST)
Show member pathways
9.2FGF2, KDR, PLG, VEGFA
169.2FGF2, FLT1, KDR, TEK
179.2FGF2, KDR, THBS1, VEGFA
18
Show member pathways
9.1FGF2, KDR, PLG, THBS1
19
Show member pathways
9.0CXCL12, FGF2, FLT1, KDR
209.0FGF2, FLT1, SLIT2, VEGFA
219.0CXCL12, FLT1, TEK, VEGFA
22
Angiogenesis (WikiPathways)
Show member pathways
8.9CXCL12, FLT1, TEK, VEGFA
238.9CXCL12, FGF2, PLG, THBS1
248.8CXCL12, ROBO1, SLIT2
258.8CXCL12, ROBO1, SLIT2
26
Show member pathways
8.7CD36, FLT1, KDR, THBS1, VEGFA
278.5FGF2, FLT1, KDR, TEK, THBS1, VEGFA
28
Show member pathways
8.5FGF2, FLT1, KDR, TEK, THBS1, VEGFA
29
Show member pathways
8.4CXCL12, FGF2, FLT1, KDR, TEK, VEGFA
30
Show member pathways
8.2CD36, HRG, PLG, THBS1, VEGFA
31
Show member pathways
8.2CD36, CXCL12, KDR, PLG, THBS1, VEGFA
32
Show member pathways
7.8CD36, HRG, PLG, TEK, THBS1, VEGFA
33
Show member pathways
7.7CD36, FGF2, KDR, ROBO1, SLIT2, TEK

GO Terms for genes affiliated with Corneal Neovascularization

About this section

Cellular components related to Corneal Neovascularization according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.3CD36, CXCL12, KDR, THBS1
2platelet alpha granule lumenGO:00310939.2HRG, PLG, THBS1, VEGFA
3cell surfaceGO:00099867.4CD36, PLG, ROBO1, SLIT2, TEK, THBS1
4extracellular spaceGO:00056157.0CD36, CXCL12, FGF2, FLT1, PLG, SERPINF1
5plasma membraneGO:00058866.2CD36, CXCL12, FLT1, HRG, KDR, PLG
6extracellular regionGO:00055765.9CXCL12, FGF2, HRG, KDR, PLG, SERPINF1

Biological processes related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show top 50)    (show all 67)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of phospholipase C activityGO:001086310.6FGF2, FLT1
2regulation of hematopoietic progenitor cell differentiationGO:190153210.6KDR, VEGFA
3positive regulation of positive chemotaxisGO:005092710.6KDR, VEGFA
4surfactant homeostasisGO:004312910.5KDR, VEGFA
5regulation of endothelial cell differentiationGO:004560110.5KDR, VEGFA
6regulation of cGMP metabolic processGO:003082310.4THBS1, VEGFA
7negative regulation of fibrinolysisGO:005191810.3PLG, THBS1
8vascular endothelial growth factor signaling pathwayGO:003808410.3FLT1, KDR, VEGFA
9cellular response to vascular endothelial growth factor stimulusGO:003592410.3FLT1, KDR, VEGFA
10positive regulation of epithelial cell proliferationGO:005067910.2FGF2, KDR, VEGFA
11positive regulation of blood vessel endothelial cell migrationGO:004353610.1FGF2, THBS1, VEGFA
12positive regulation of axon extension involved in axon guidanceGO:004884210.1CXCL12, VEGFA
13positive regulation of phosphatidylinositol 3-kinase activityGO:004355210.1FGF2, FLT1, TEK
14chemorepulsion involved in postnatal olfactory bulb interneuron migrationGO:002183610.1ROBO1, SLIT2
15positive regulation of MAP kinase activityGO:004340610.1FGF2, FLT1, VEGFA
16Roundabout signaling pathwayGO:003538510.1ROBO1, SLIT2
17positive regulation of MAPK cascadeGO:004341010.0CD36, FLT1, KDR
18positive regulation of phosphatidylinositol 3-kinase signalingGO:001406810.0FLT1, KDR, TEK
19negative regulation of chemokine-mediated signaling pathwayGO:00701009.9ROBO1, SLIT2
20positive chemotaxisGO:00509189.9CXCL12, FGF2, VEGFA
21positive regulation of protein kinase B signalingGO:00518979.9FGF2, TEK, THBS1
22branching morphogenesis of an epithelial tubeGO:00487549.9KDR, SLIT2, VEGFA
23negative regulation of endothelial cell chemotaxisGO:20010279.9HRG, THBS1
24mammary duct terminal end bud growthGO:00607639.8ROBO1, SLIT2
25telencephalon cell migrationGO:00220299.8CXCL12, SLIT2
26negative regulation of lamellipodium assemblyGO:00105939.8HRG, SLIT2
27blood vessel morphogenesisGO:00485149.8FLT1, THBS1, VEGFA
28positive regulation of cell adhesionGO:00457859.8CXCL12, TEK, VEGFA
29negative regulation of endothelial cell migrationGO:00105969.8SERPINF1, SLIT2, THBS1
30negative regulation of inflammatory responseGO:00507289.8SERPINF1, SLIT2, TEK
31positive regulation of protein phosphorylationGO:00019349.7FGF2, KDR, TEK, VEGFA
32negative regulation of blood vessel endothelial cell migrationGO:00435379.6FGF2, HRG, THBS1
33positive regulation of endothelial cell migrationGO:00105959.4FGF2, KDR, TEK, THBS1, VEGFA
34positive regulation of focal adhesion assemblyGO:00518949.3HRG, KDR, TEK, VEGFA
35response to hypoxiaGO:00016669.2CXCL12, TEK, THBS1, VEGFA
36positive regulation of ERK1 and ERK2 cascadeGO:00703749.2CD36, FGF2, KDR, TEK, VEGFA
37positive regulation of cell proliferationGO:00082849.2CXCL12, FGF2, FLT1, KDR, VEGFA
38positive regulation of endothelial cell proliferationGO:00019389.2CXCL12, FGF2, KDR, TEK, VEGFA
39vascular endothelial growth factor receptor signaling pathwayGO:00480109.2FGF2, FLT1, KDR, TEK, VEGFA
40cell migration involved in sprouting angiogenesisGO:00020429.1FGF2, KDR, ROBO1, SLIT2, VEGFA
41negative regulation of angiogenesisGO:00165259.1HRG, SERPINF1, TEK, THBS1
42positive regulation of cell migrationGO:00303359.0CXCL12, FLT1, KDR, THBS1, VEGFA
43positive regulation of angiogenesisGO:00457668.9FGF2, FLT1, KDR, TEK, THBS1, VEGFA
44cell migrationGO:00164778.8FLT1, KDR, THBS1, VEGFA
45platelet degranulationGO:00025768.8CD36, HRG, PLG, THBS1, VEGFA
46angiogenesisGO:00015258.6FGF2, FLT1, HRG, KDR, TEK, VEGFA
47axon guidanceGO:00074118.4CXCL12, FGF2, ROBO1, SLIT2, TEK
48negative regulation of cell proliferationGO:00082858.3FGF2, HRG, PLG, ROBO1, SLIT2
49platelet activationGO:00301688.2CD36, HRG, PLG, THBS1, VEGFA
50blood coagulationGO:00075967.7CD36, HRG, PLG, TEK, THBS1, VEGFA

Molecular functions related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1vascular endothelial growth factor-activated receptor activityGO:000502110.4FLT1, KDR
2fibronectin bindingGO:000196810.1THBS1, VEGFA
3low-density lipoprotein particle bindingGO:003016910.0CD36, THBS1
4transforming growth factor beta bindingGO:005043110.0CD36, THBS1
5extracellular matrix bindingGO:005084010.0THBS1, VEGFA
6growth factor bindingGO:00198389.9FLT1, KDR, TEK
7proteoglycan bindingGO:00433949.7SLIT2, THBS1
8chemoattractant activityGO:00420569.7CXCL12, FGF2, VEGFA
9growth factor activityGO:00080839.7CXCL12, FGF2, VEGFA
10heparan sulfate proteoglycan bindingGO:00433959.6HRG, SLIT2
11transmembrane receptor protein tyrosine kinase activityGO:00047149.5FLT1, KDR, TEK
12protein tyrosine kinase activityGO:00047139.2FLT1, KDR, TEK
13receptor bindingGO:00051028.6CXCL12, HRG, PLG, VEGFA
14heparin bindingGO:00082018.3FGF2, HRG, SLIT2, THBS1, VEGFA

Sources for Corneal Neovascularization

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet